The efficacy of a low-dose combination of febuxostat and benzbromarone versus each drug used alone for the treatment of gout
Our study did not identify a difference in the efficacy of reducing uric acid excretion in gout patients when comparing conventional dose febuxostat and benzbromarone monotherapy versus low-dose combination therapy.
Authors
- Ser Tong Quek (ORCID: https://orcid.org/0000-0002-8514-0699)
- Yanmei Lin
- Caiyu Zheng
- Duk‐Hee Kang (ORCID: https://orcid.org/0000-0001-8475-8932)
- Zhijun Zhang (ORCID: https://orcid.org/0000-0002-6859-3426)
- Zhiyi Wang (ORCID: https://orcid.org/0000-0001-8280-9097)
- Chunmei Lin
- Jianqing Tian (ORCID: https://orcid.org/0000-0003-4889-2231)
Institutions
- Fujian Medical University (CN)
- Xiamen University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-02-07
- DOI
- https://doi.org/10.3389/fmed.2025.1469879
- Citations
- 1
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 1.43